Neuroprotection Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
SILK | A | Silk Road Medical, Inc. | 0.00 | |
AVXL | B | Anavex Life Sciences Corp. | 6.43 | |
ANVS | F | Annovis Bio, Inc. | 0.31 |
Related Industries: Biotechnology Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ARB | B | AltShares Merger Arbitrage ETF | 2.16 | |
EVNT | B | AltShares Event-Driven ETF | 1.46 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 0.42 | |
XBI | D | SPDR S&P Biotech ETF | 0.17 | |
IWC | B | iShares Microcap ETF | 0.15 |
Compare ETFs
- Neuroprotection
Neuroprotection refers to the relative preservation of neuronal structure and/or function. In the case of an ongoing insult (a neurodegenerative insult) the relative preservation of neuronal integrity implies a reduction in the rate of neuronal loss over time, which can be expressed as a differential equation. It is a widely explored treatment option for many central nervous system (CNS) disorders including neurodegenerative diseases, stroke, traumatic brain injury, spinal cord injury, and acute management of neurotoxin consumption (i.e. methamphetamine overdoses). Neuroprotection aims to prevent or slow disease progression and secondary injuries by halting or at least slowing the loss of neurons. Despite differences in symptoms or injuries associated with CNS disorders, many of the mechanisms behind neurodegeneration are the same. Common mechanisms include increased levels in oxidative stress, mitochondrial dysfunction, excitotoxicity, inflammatory changes, iron accumulation, and protein aggregation. Of these mechanisms, neuroprotective treatments often target oxidative stress and excitotoxicity—both of which are highly associated with CNS disorders. Not only can oxidative stress and excitotoxicity trigger neuron cell death but when combined they have synergistic effects that cause even more degradation than on their own. Thus limiting excitotoxicity and oxidative stress is a very important aspect of neuroprotection. Common neuroprotective treatments are glutamate antagonists and antioxidants, which aim to limit excitotoxicity and oxidative stress respectively.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles